Miswak’s Extract for Oral Care Reduces VAP Risk in Ventilated Patients: A Case Study

Fariz Jauhar Muslim; Arifin Dwi Atmaja

doi:10.56741/hesmed.v5i01.2185

Authors

Fariz Jauhar Muslim
almasena75@gmail.com
Bhamada Slawi University
Arifin Dwi Atmaja Bhamada Slawi University

DOI:

https://doi.org/10.56741/hesmed.v5i01.2185

Keywords:

Healthcare Infection, Intensive Care Unit, Miswak’s Extract, Oral Care, Ventilator-associated Pneumonia

Abstract

Ventilator-Associated Pneumonia (VAP) is a common nosocomial infection among patients receiving mechanical ventilation and is associated with increased morbidity, mortality, and prolonged length of stay in the intensive care unit (ICU). Poor oral hygiene is a key contributor to oropharyngeal bacterial colonization, which may facilitate the development of VAP. Miswak (Salvadora persica L.) contains natural antibacterial compounds and has potential as an alternative oral care intervention in nursing practice. This study employed an Evidence-Based Practice case study approach involving a mechanically ventilated patient in the ICU. Oral care using miswak extract was implemented for three consecutive days according to the established nursing care plan. Oral health status was assessed using the Beck Oral Assessment Score (BOAS), while the risk of VAP was evaluated using the Clinical Pulmonary Infection Score (CPIS). Following the intervention, oral hygiene improved significantly, as indicated by a reduction in the BOAS score from 7 to 3. The risk of VAP also decreased, demonstrated by a decline in the CPIS score from 7 (high risk) to 3 (low risk), accompanied by reduced purulent secretions and stable clinical parameters. These findings suggest that oral care using miswak extract is effective in improving oral hygiene and reducing VAP risk and may be recommended as a safe, practical, and evidence-based preventive intervention in ICU nursing practice.

Downloads

Download data is not yet available.

Author Biographies

Fariz Jauhar Muslim, Bhamada Slawi University

is an active nursing student currently enrolled in the clinical stage of the professional nursing (Ners) program. He is actively involved in various scientific research activities. He is affiliated with the Professional Nursing (Ners) Program, Faculty of Health Sciences, Universitas Bhamada Slawi, located at Jalan Cut Nyak Dhien No. 16, Kalisapu Village, Slawi District, Tegal Regency, Central Java, 52416, Indonesia. (email: almasena75@gmail.com).

Arifin Dwi Atmaja, Bhamada Slawi University

is a lecturer in the field of nursing science, specializing in medical-surgical nursing with a focus on emergency care. He has extensive experience supervising students in various research projects, particularly within the scope of medical-surgical and emergency nursing. He is affiliated with the Professional Nursing (Ners) Program, Faculty of Health Sciences, Universitas Bhamada Slawi, located at Jalan Cut Nyak Dhien No. 16, Kalisapu Village, Slawi District, Tegal Regency, Central Java, 52416, Indonesia. (email: arifindwiatmaja@gmail,com).

References

E. Campisi et al., “Evaluation of preventive interventions addressing healthcare-associated infections and antimicrobial resistance: a systematic review,” Journal of Hospital Infection, vol. 171, pp. 120–136, 2026, doi: https://doi.org/10.1016/j.jhin.2026.02.015. DOI: https://doi.org/10.1016/j.jhin.2026.02.015

E. Tobin and Z. F, “Nosocomial Infections,” in Statpearls, StatPearls Publisher, 2025, pp. 1–62. [Online]. Available: https://www.ncbi.nlm.nih.gov/books/NBK559312/

L. P. Wah Goh, H. Marbawi, S. M. Goh, A. K. bin Abdul Asis, and J. A. Gansau, “The prevalence of hospital-acquired infections in Southeast Asia (1990-2022),” J. Infect. Dev. Ctries., vol. 17, no. 2, pp. 139–146, 2023, doi: 10.3855/JIDC.17135. DOI: https://doi.org/10.3855/jidc.17135

A. Odoom and E. S. Donkor, “Prevalence of Healthcare‐Acquired Infections Among Adults in Intensive Care Units: A Systematic Review and Meta‐Analysis,” Health Sci. Rep., vol. 2, no. 2, pp. 1–13, 2025, [Online]. Available: https://doi.org/10.1002/hsr2.70939 DOI: https://doi.org/10.1002/hsr2.70939

F. Howroyd et al., “Ventilator-associated pneumonia: mechanisms, an appraisal of current therapies and the role for inhaled antibiotics in prevention and treatment,” Respir. Med., vol. 247, no. May, p. 108275, 2025, doi: 10.1016/j.rmed.2025.108275. DOI: https://doi.org/10.1016/j.rmed.2025.108275

H. Mumtaz et al., “Ventilator-associated pneumonia in intensive care unit patients: a systematic review,” Annals of Medicine and Surgery, vol. 40, no. SUPPL. 1, pp. 2932–2939, 2023, doi: 10.4236/ojrd.2022.122004. DOI: https://doi.org/10.1097/MS9.0000000000000836

E. M. Tegegne, B. Chekol Gete, and D. B. Demissie, “Prevalence of ventilator-associated pneumonia and associated factors among intubated adult patients admitted in public hospitals in Addis Ababa, Ethiopia: a facility-based retrospective study design,” Front. Med. (Lausanne)., vol. 12, no. April, pp. 1–10, 2025, doi: 10.3389/fmed.2025.1500901. DOI: https://doi.org/10.3389/fmed.2025.1500901

S. Hlinkova, E. Moraucikova, A. Strzelecka, M. Mrazova, and V. Littva, “Ventilator-Associated Pneumonia in Intensive Care Units: A Comparison of Pre-Pandemic and COVID-19 Periods,” J. Clin. Med., vol. 14, no. 3, pp. 1–14, 2025, doi: 10.3390/jcm14031000. DOI: https://doi.org/10.3390/jcm14031000

H. Huang, X. Yu, C. Huang, J. Zeng, and Y. Li, “Oral care medications for the prevention and treatment of ventilator-associated pneumonia in intensive care unit,” Frontiers in Oral Health, vol. 6, no. March, pp. 1–7, 2025, doi: 10.3389/froh.2025.1566355. DOI: https://doi.org/10.3389/froh.2025.1566355

M. A. Nurhayati, “Efektivitas Mouthcare Dengan Clorhexidin Terhadap Pencegahan Vap Pada Pasien Dengan Bantuan Ventilasi Mekanik,” Jurnal Kesmas Asclepius, vol. 6, pp. 1–23, 22024.

N. komang T. Pramesuari, H. Ruris, R. A. Yunanto, and Y. T. Handoko, “Pengaruh Pemberian Oral Hygiene dengan Povidone Iodine 1% Terhadap Pencegahan Kejadian Ventilator Associated Pneumonia (VAP) di Ruang ICU RSUD Dr . Haryoto Lumajang,” Jurnal Ilmiah Keperawatan Altruistik, vol. 7, no. 2, 2024. DOI: https://doi.org/10.48079/jika.v7i2.115

K. P. W. Puspa, R. Haristiani, B. Setioputro, and H. Siswanto, “Efektivitas Pemberian Oral Hygiene + Close Suction + Head Up 30-45? Sebagai Bundle Pencegahan VAP (Ventilator Associated Pneumonia) pada Responden Tn. S dengan Penggunaan Ventilator Mekanik di Ruang ICU RSUP Prof Dr. I. G. N. G. Ngoerah Bali,” Jurnal Ilmiah Keperawatan Altruistik, vol. 7, no. 1, pp. 34–41, 2024, doi: 10.48079/jika.v7i1.107. DOI: https://doi.org/10.48079/jika.v7i1.107

P. C. Vieira, R. B. de Oliveira, and T. M. da Silva Mendonça, “Should oral chlorhexidine remain in ventilator-associated pneumonia prevention bundles?,” Med. Intensiva, vol. 46, no. 5, pp. 259–268, 2022, doi: https://doi.org/10.1016/j.medin.2020.09.009. DOI: https://doi.org/10.1016/j.medin.2020.09.009

S. S. Abdeltawab, T. S. Abu Haimed, H. A. Bahammam, W. T. Arab, E. A. Abou Neel, and L. A. Bahammam, “Biocompatibility and Antibacterial Action of Salvadora persica Extract as Intracanal Medication (In Vitro and Ex Vivo Experiment),” Materials, vol. 15, no. 4, 2022, doi: 10.3390/ma15041373. DOI: https://doi.org/10.3390/ma15041373

M. K. Almaghrabi, “Antimicrobial activity of salvadora persica on streptococcus pneumoniae,” Biomedical Research (India), vol. 29, no. 19, pp. 3635–3637, 2018, doi: 10.4066/biomedicalresearch.29-18-1081. DOI: https://doi.org/10.4066/biomedicalresearch.29-18-1081

H. Balto et al., “Synergistic effect of Salvadora persica and chitosan nanoparticles against oropharyngeal microorganisms,” Sci. Rep., vol. 14, no. 1, pp. 1–11, 2024, doi: 10.1038/s41598-024-63636-1. DOI: https://doi.org/10.1038/s41598-024-63636-1

M. Yazdi, J. Akhtari, A. Davoodi, I. Haghani, Z. Kiadehi, and H. R. Goli, “Antibacterial and antifungal effect of Salvadora persica L. root extract, essential oil, and nanoemulsion,” J. Herb. Med., vol. 54, p. 101058, 2025, doi: https://doi.org/10.1016/j.hermed.2025.101058. DOI: https://doi.org/10.1016/j.hermed.2025.101058

A. Unahalekhaka, P. Uirungroj, and C. Saenjum, “Impact of single-use oral care sets on reducing ventilator-associated pneumonia among intensive care unit patients: a multi-centre study,” Journal of Hospital Infection, vol. 160, pp. 12–18, 2025, doi: 10.1016/j.jhin.2025.03.005. DOI: https://doi.org/10.1016/j.jhin.2025.03.005

M. I. Bocicor et al., “Technological platform for the prevention and management of healthcare associated infections and outbreaks,” Communications in Computer and Information Science, vol. 866, pp. 70–90, 2018, doi: 10.1007/978-3-319-94135-6_4. DOI: https://doi.org/10.1007/978-3-319-94135-6_4

M. Klompas et al., “Strategies to prevent ventilator-associated pneumonia, ventilator-associated events, and nonventilator hospital-acquired pneumonia in acute-care hospitals: 2022 Update,” Infect. Control Hosp. Epidemiol., vol. 43, no. 6, pp. 687–713, 2022, doi: 10.1017/ice.2022.88. DOI: https://doi.org/10.1017/ice.2022.88

W. Li, J. Cai, L. Ding, Y. Chen, X. Wang, and H. Xu, “Incidence and risk factors of ventilator-associated pneumonia in the intensive care unit: a systematic review and meta-analysis,” J. Thorac. Dis., vol. 16, no. 9, pp. 5518–5528, 2024, doi: 10.21037/jtd-24-150. DOI: https://doi.org/10.21037/jtd-24-150

K. Sridharan, G. Sivaramakrishnan, and G. A. Alotaibi, “Oropharyngeal Interventions in Intubated Patients for Preventing Ventilator Associated Pneumonia: A Systematic Review and Multi-Variate Network Meta-Analysis Evaluating Pharmacological Agents,” J. Clin. Med., vol. 14, no. 22, 2025, doi: 10.3390/jcm14228174. DOI: https://doi.org/10.3390/jcm14228174

F. Howroyd et al., “Ventilator-associated pneumonia: pathobiological heterogeneity and diagnostic challenges,” Nat. Commun., vol. 15, no. 1, 2024, doi: 10.1038/s41467-024-50805-z. DOI: https://doi.org/10.1038/s41467-024-50805-z

T. Zhao, X. Wu, Q. Zhang, C. Li, H. V. Worthington, and F. Hua, “Oral hygiene care for critically ill patients to prevent ventilator-associated pneumonia,” Cochrane Database of Systematic Reviews, vol. 2020, no. 12, 2020, doi: 10.1002/14651858.CD008367.pub4. DOI: https://doi.org/10.1002/14651858.CD008367.pub4

P. Singh, Z. Arshad, V. K. Srivastava, G. P. Singh, and R. S. Gangwar, “Efficacy of Oral Care Protocols in the Prevention of Ventilator-Associated Pneumonia in Mechanically Ventilated Patients,” Cureus, vol. 14, no. 4, 2022, doi: 10.7759/cureus.23750. DOI: https://doi.org/10.7759/cureus.23750

E. B. Mohammad et al., “Oral Care and Positioning to Prevent Ventilator-Associated Pneumonia: A Systematic Review,” SAGE Open Nurs., vol. 10, 2024, doi: 10.1177/23779608241271699. DOI: https://doi.org/10.1177/23779608241271699

P. Yunus, H. Damansyah, and A. S. Talib, “Pengaruh Oral Hygiene Terhadap Pencegahan Ventilator Associated Pneumonia (Vap) Di Ruang Icu,” Prepotif : Jurnal Kesehatan Masyarakat, vol. 9, no. 1, pp. 2630–2638, 2025, doi: 10.31004/prepotif.v9i1.41374. DOI: https://doi.org/10.31004/prepotif.v9i1.41374

Pitriani, Lismawati, and Yohana Adelina Pasaribu, “Effect of Oral Hygiene on Prevention Ventilator Associated Pneumonia (VAP) in The Intensive Room of The Hospital Granmed Lubuk Pakam in 2023,” Jurnal Keperawatan Dan Fisioterapi (Jkf), vol. 6, no. 1, pp. 128–133, 2023, doi: 10.35451/jkf.v6i1.1883. DOI: https://doi.org/10.35451/jkf.v6i1.1883

H. Irani, G. Sargazi, A. Dahmardeh Rahat, and Z. Mofrad Pishkar, “The comparison effects of oral care with Salvadora persica chewing stick (miswak) and chlorhexidine mouthwash on the incidence of ventilator-associated pneumonia among patients hospitalized in intensive care units of Khatam Hospital in Zahedan, 2019,” Med Surg Nurs Journal, vol. 8, no. 4, 2020, doi: 10.5812/msnj.100387.Research. DOI: https://doi.org/10.5812/msnj.100387

G. M. El-Sherbiny et al., “Exploitation of the antibacterial, antibiofilm and antioxidant activities of Salvadora Persica (Miswak) extract,” Journal of Bioresources and Bioproducts, vol. 8, no. 1, pp. 59–65, 2023, doi: 10.1016/j.jobab.2022.11.006. DOI: https://doi.org/10.1016/j.jobab.2022.11.006

A. Veyisoğlu, Y. E. Balta, and D. Tatar, “Investigation of the antimicrobial activity of water and methanol extracts of Salvadora persica L. (Miswak) plant against some pathogenic microorganisms,” International Journal of Agriculture Environment and Food Sciences, vol. 8, no. 4, pp. 964–969, 2024, doi: 10.31015/jaefs.2024.4.25. DOI: https://doi.org/10.31015/jaefs.2024.4.25

A. I. Jamal and S. T. Jalal Balaky, “The effect of Sub-MIC of Salvadora persica on growth and virulence gene expressions in Streptococcus mutatis,” Cell. Mol. Biol., vol. 69, no. 6, pp. 88–94, 2023, doi: 10.14715/cmb/2023.69.6.14. DOI: https://doi.org/10.14715/cmb/2023.69.6.14

Mahboob and Shahzad, “Biological and Clinical Sciences Research Journal,” Biological and Clinical Sciences Research Journal, no. 13, pp. 1–8, 2022.

F. J. Muslim, “Miswak ( Salvadora Persica L ) as Oral Care on Ventilated Patients in ICU: A Systematic Review and Meta Analysis of Randomized Controlled Trials,” Jurnal Multidiscipliner Kapalamada, vol. 4, no. 03, pp. 359–372, 2025, [Online]. Available: https://doi.org/10.62668/kapalamada.v4i03.1697

S. Beck, “Impact of a systematic oral care protocol on stomatitis after chemotherapy,” Cancer Nurs., vol. 2, no. 3, 1979, [Online]. Available: https://journals.lww.com/cancernursingonline/fulltext/1979/06000/impact_of_a_systematic_oral_care_protocol_on.2.aspx DOI: https://doi.org/10.1097/00002820-197906000-00002

B. T. Qurdahji, R. M. Alassaf, and R. S. Abu Qbitah, “The Impact of Miswak (Salvadora Persica) on Periodontal Health: A Review,” South East. Eur. J. Public Health, vol. XXV, pp. 1212–1219, 2024, doi: 10.70135/seejph.vi.2373. DOI: https://doi.org/10.70135/seejph.vi.2373

F. H. Kiabi, A. G. Baradari, A. Z. Kiasari, and M. Shahheidari, “The Difference in Mouthwash Side Effects of Persica and Chlorhexidine for Preventing Ventilator-induced Pneumonia among Patients Admitted to the Intensive Care Unit,” Open Public Health J., vol. 16, no. 1, pp. 1–6, 2023, doi: 10.2174/18749445-v16-e230607-2022-134. DOI: https://doi.org/10.2174/18749445-v16-e230607-2022-134

M. K. Kia, “Comparing the Effectiveness of Miswak+Aloe Vera Mouthwash with Chlorhexidine Mouthwash on the Prevention of Ventilator-Induced Pneumonia: A Randomized Clinical Trial,” Complementary Medicine Journal, vol. 14, no. 2, pp. 51–60, 2024, doi: 10.32592/cmja.14.2.51. DOI: https://doi.org/10.32592/cmja.14.2.51

P. Batra, P. Mathur, M. C. Misra, M. Kumari, O. Katoch, and F. Hasan, “Ventilator Associated Pneumonia in Adult Patients Preventive Measures : A Review of the Recent Advances,” vol. 1, no. 3, pp. 8–12, 2018. DOI: https://doi.org/10.29245/2689-9981/2018/3.1122

Z. F. O. Hunaydi, N. A. A. Shafiai, S. N. F. M. Noor, and N. R. A. Rahman, “Clinical Effects, Uses and Applications of Miswak (Salvadora Persica) on Oral Health Over the Last Three Decades: a Scoping Review of Literature,” Journal of Health and Translational Medicine, vol. 2023, no. Special Issue 1, pp. 310–324, 2023, doi: 10.22452/jummec.sp2023no1.33. DOI: https://doi.org/10.22452/jummec.sp2023no1.33